Sandbox GGC12

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 9: Line 9:
HSA is involved in two important diseases, Hyperthyroxinemia, familial dysalbuminemic (FDAH) and Analbuminemia (ANALBA).
HSA is involved in two important diseases, Hyperthyroxinemia, familial dysalbuminemic (FDAH) and Analbuminemia (ANALBA).
-
First, FDAH is a condition based on the genetic composition of the individual. It is caused by a mutation in the ALB gene, which corresponds to an increased affinity of the protein HSA for thyroxine. In detail, this autosomal dominant genetic disorder is characterized by the mutation of HSA causing the assembly of thyroxine in a higher proportion. There are two positions with three natural variants identified on the HSA that mutate to cause this disorder. The first position is at 90 amino acid, where leucine is replaced by a proline. The second position at 242 amino acid, where arginine is substituted by histidine or proline. This disorder could lead to confusion and several misdiagnoses of hyperthyroidism because it is difficult to detect it due to the normal TSH and free thyroxine levels but with an elevated total of thyroxine <ref>PMID: 32665066</ref>.
+
First, FDAH is a condition based on the genetic composition of the individual. It is caused by a mutation in the ALB gene, which corresponds to an increased affinity of the protein HSA for thyroxine. In detail, this autosomal dominant genetic disorder is characterized by the mutation of HSA causing the assembly of thyroxine in a higher proportion. There are two positions with three natural variants identified on the HSA that mutate to cause this disorder. The first position (red) is at 90 amino acid, where leucine is replaced by a proline. The second position (green) at 242 amino acid, where arginine is substituted by histidine or proline <scene name='78/781196/Hyperthyroxinemia/1'>3D View</scene>. This disorder could lead to confusion and several misdiagnoses of hyperthyroidism because it is difficult to detect it due to the normal TSH and free thyroxine levels but with an elevated total of thyroxine <ref>PMID: 32665066</ref>.
Second, ANALBA is an uncommon autosomal recessive genetic mutation characterized by the identification of very low levels of HSA circulating in the bloodstream <ref>PMID: 8134387</ref>. The affected individuals have symptoms corresponding to mild edema, hypotension, fatigue, and lower body lipodystrophy in females. The mutagenesis is located in the position 91 where histidine is replaced by alanine impairing metal binding <ref>PMID: 28567254</ref>. The complications of this disorder could lead to early atherosclerosis and heart problems.
Second, ANALBA is an uncommon autosomal recessive genetic mutation characterized by the identification of very low levels of HSA circulating in the bloodstream <ref>PMID: 8134387</ref>. The affected individuals have symptoms corresponding to mild edema, hypotension, fatigue, and lower body lipodystrophy in females. The mutagenesis is located in the position 91 where histidine is replaced by alanine impairing metal binding <ref>PMID: 28567254</ref>. The complications of this disorder could lead to early atherosclerosis and heart problems.

Revision as of 19:12, 28 April 2021

Human Serum Albumin

Serum Albumin Protein

Drag the structure with the mouse to rotate

References

  1. Dugaiczyk A, Law SW, Dennison OE. Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A. 1982 Jan;79(1):71-5. PMID:6275391
  2. Morinaga T, Sakai M, Wegmann TG, Tamaoki T. Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4604-8. PMID:6192439
  3. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. PMID:10388840
  4. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999 Jun;12(6):439-46. PMID:10388840
  5. Pardridge WM. Plasma protein-mediated transport of steroid and thyroid hormones. Am J Physiol. 1987 Feb;252(2 Pt 1):E157-64. doi: 10.1152/ajpendo.1987.252.2.E157. PMID:3548415 doi:http://dx.doi.org/10.1152/ajpendo.1987.252.2.E157
  6. Lu J, Stewart AJ, Sadler PJ, Pinheiro TJ, Blindauer CA. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans. 2008 Dec;36(Pt 6):1317-21. doi: 10.1042/BST0361317. PMID:19021548 doi:10.1042/BST0361317
  7. Konopka K, Neilands JB. Effect of serum albumin on siderophore-mediated utilization of transferrin iron. Biochemistry. 1984 May 8;23(10):2122-7. doi: 10.1021/bi00305a003. PMID:6234017 doi:http://dx.doi.org/10.1021/bi00305a003
  8. Lai S, Gopalakrishnan G, Li J, Liu X, Chen Y, Wen Y, Zhang S, Huang B, Phornphutkul C, Liu S, Kuang J. Familial Dysalbuminemic Hyperthyroxinemia (FDH), Albumin Gene Variant (R218S), and Risk of Miscarriages in Offspring. Am J Med Sci. 2020 Nov;360(5):566-574. doi: 10.1016/j.amjms.2020.05.035. Epub, 2020 May 28. PMID:32665066 doi:http://dx.doi.org/10.1016/j.amjms.2020.05.035
  9. Watkins S, Madison J, Galliano M, Minchiotti L, Putnam FW. A nucleotide insertion and frameshift cause analbuminemia in an Italian family. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2275-9. doi: 10.1073/pnas.91.6.2275. PMID:8134387 doi:http://dx.doi.org/10.1073/pnas.91.6.2275
  10. Handing KB, Shabalin IG, Kassaar O, Khazaipoul S, Blindauer CA, Stewart AJ, Chruszcz M, Minor W. Circulatory zinc transport is controlled by distinct interdomain sites on mammalian albumins. Chem Sci. 2016 Nov 1;7(11):6635-6648. doi: 10.1039/c6sc02267g. Epub 2016 Aug 15. PMID:28567254 doi:http://dx.doi.org/10.1039/c6sc02267g
  11. Wenskowsky L, Wagner M, Reusch J, Schreuder H, Matter H, Opatz T, Petry SM. Resolving Binding Events on the Multifunctional Human Serum Albumin. ChemMedChem. 2020 Mar 11. doi: 10.1002/cmdc.202000069. PMID:32162429 doi:http://dx.doi.org/10.1002/cmdc.202000069
Personal tools